Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. (Lancet, 1998)

(untitled) - Ebers, G; Rice, G; Lesaux, J; Paty, D; Oger, J; Li, D; Beall, S; Devonshire, V; Hashimoto, S; Hooge, J; Kastrukoff, L; Krieger, C; et al.